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Abstract 
γ-secretase produces β-amyloid (Aβ) within its presenilin (PS1) subunit, mutations in which cause 
Alzheimer’s disease, and current therapies thus seek to modulate its activity. While the general 
structure is known from recent electron microscopy studies, direct loop- and membrane-interactions 
and explicit dynamics relevant to substrate processing remain unknown. We report a modeled structure 
utilizing the optimal multi-template information available, including loops and missing side chains, 
account of maturation cleavage, and explicit all-atom molecular dynamics in the membrane. We 
observe three distinct conformations of γ-secretase (open, semi-open, and closed) that remarkably 
differ by tilting of helix 2 and 3 of PS1, directly controlling active site availability. The large 
hydrophilic loop of PS1 where maturation occurs reveals a new helix segment that parallels the likely 
helix character of other substrates. The semi-open conformation consistently shows the best fit of Aβ 
peptides, i.e. longer residence before release and by inference more trimming. In contrast, the closed, 
hydrophobic conformation is largely inactive and the open conformation is active but provides fewer 
optimal interactions and induces shorter residence time and by inference releases Aβ peptides of longer 
lengths. Our simulations thus provide a molecular basis for substrate processing and changes in the 
Aβ42/Aβ40 ratio. Accordingly, selective binding to protect the semi-open “innocent” conformation 
provides a molecular recipe for effective γ-secretase modulators; we provide the full atomic structures 
for these states that may play a key role in developing selective γ-secretase modulators for treatment of 
Alzheimer’s disease. 
Keywords: γ-secretase; PSEN1; Alzheimer’s Disease; conformation change; β-amyloid. 
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Introduction 
γ-secretase is a transmembrane protein complex comprised of four protein subunits: Nicastrin, 
presenilin 1 or 2 (PS1, PS2), anterior pharynx-defective 1 (APH1), and presenilin enhancer 2 (PEN2)1–
3. As an aspartyl protease it catalyzes intramembrane proteolysis of numerous type-1 membrane 
proteins, including the C-terminal C99 fragment4,5 of the amyloid precursor protein (APP), produced 
upon cleavage by BACE1 (β-secretase), and the Notch receptor6. The first of these reactions involves 
sequential ε- and γ-cleavages by PS, the catalytic subunit of γ-secretase, to produce the notorious β-
amyloid (Aβ) peptides of different lengths (37−49 residues)7,8. Among these, Aβ40 and Aβ42 are 
thought to play a key role in Alzheimer’s disease (AD)9, notably via their Aβ42/Aβ40 ratio10. 
The mechanism whereby γ-secretase produces Aβ peptides of variable length and toxicity is of 
considerable interest as a forefront of current drug development efforts6,11. Strict γ-secretase inhibitors 
such as semagacestat have shown adverse side effects in clinical trials12,13, partly due to lack of 
substrate specificity between APP and other substrates such as Notch6,14. Focus is moving towards 
modulators of Aβ production rather than strict inhibitors11,14,15. 
Until recently, little was known of the detailed structure and dynamics except for the general 
transmembrane topology16,17, but many types of data together imply conformational modulation of 
distinct substrate orientations within the catalytic pocket18,19. A major step forward was the 
observations leading to the step-wise three-amino acid spaced trimming mechanism7,8,20,21: The 
complex processes C99, after its guidance via nicastrin and PEN222, by two main pathways leading to 
Aβ49 or Aβ48, followed by consecutive tri-amino acid spaced cleavage to produce shorter isoforms, 
dominated by Aβ40 or Aβ42 isoforms7. Another major step forward were the 3-dimensional structures 
using cryo-electron-microscopy at resolutions 3.4−4.4 Å23–25. These structures revealed the intact 
topology of γ-secretase with 20 transmembrane (TM) helices (1, 9, 7, and 3 from nicastrin, presenilin 1 
(PS1), APH-1, and PEN2 respectively). While nicastrin features a single TM helix and a large dynamic 
extracellular domain that probably helps to size-discriminate potential substrates26,27, APH-1 and PEN2 
mostly traverse through the membrane to potentially modulate PS1 stability and endoproteolysis3. 
Notably, disorder in TM2 of PS1 was speculated to be mechanistically important24,28; the atomic 
motions producing this disorder are unknown. 
Despite these efforts, multiple key features remain unknown: Most importantly, the large 
hydrophilic loop in PS1 (residues 273–374 from exon 8, 9 and 10) where autocatalytic cleavage occurs 
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is missing in all reported structures. The structures indicate flexible regions of PS1, notably TM2, 
TM6, and the large hydrophilic loop. These particular dynamic parts may hold the secret to the peculiar 
substrate processing by γ-secretase29–31. Thus, the dynamics of γ-secretase with these parts included in 
a membrane is of major interest. Also, PS1 undergoes auto-endoproteolysis between TM6 and TM7, 
resulting in mature N-terminal (NTF) and C-terminal (CTF) fragments that are catalytically active, and 
with few exceptions this is required for function. Thus, modeling the mature, cleaved loop and its role 
in processing seems warranted32; previous simulations and experiments on PS1 suggests that this 
mature loop functions as a plug that, together with PEN2, controls cytosolic access to the active 
site31,33, whereas nicastrin provides extracellular size control26.  
We aimed to understand the full conformational dynamics of mature γ-secretase in the 
membrane with these features included. This required building a complete model using experimental 
constraints and templates for all subunits and additional multi-template modeling of missing residues 
and loops, the establishment of a realistic matured membrane-embedded system, and all-atom 
molecular dynamics (MD) in a physiologically relevant cellular environment (neutral pH, physiological 
ion strength, all-atom protein and explicit solvent). The resulting model is in full accordance with 
known experimental structural data (~0.5−0.6 Å RMSD) and provides the most complete γ-secretase 
structure so far described. We subjected this system to three 500 ns seeded MD simulations to explore 
the conformational ensemble of this system in atomic detail.  
The simulations reveal three distinct conformational states of PS1 that explain the electron 
microscopy disorder in this subunit, while also providing insight into how the mature loop modulates 
these motions. Importantly, the three distinct conformations differ mainly in the C-terminal part of 
TM2 and N-terminal part of TM3 of PS1 very near the two catalytic aspartates. Recurrence of these 
states and the contacts preventing broader motions support the completeness and relevance of our 
identified motions, although the exact quantitative nature of these motions will depend on details of 
force fields and membrane model. Docking simulations for both Aβ42 and Aβ40 revealed that the semi-
open conformation optimally fits the peptides, causes stronger binding and accordingly slower release 
and prolonged processing of peptides. We conclude that the semi-open conformation is the “innocent” 
and proficient active state of γ-secretase, whereas the closed and open conformations lead to inactivity 
or longer isoforms, respectively. Thus, our model provides a molecular basis for substrate processing 
by γ-secretase and indicates that the open conformation should be selectively targeted while the semi-
open conformation should be preserved or enforced by structure-dynamics guided therapies. 
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Figure 1. Structural model of membrane-bound γ-secretase. A) Simulated γ-secretase model with 
the four subunits Nicastrin (green), PS1 (cyan), APH-1 (magenta) and PEN-2 (yellow). Solvent and 
front row lipids were removed for better view. B) Two perpendicular views of multi-template PS1 
(cyan) aligned with its templates 5FN3 (light pink) and our previously developed PS1 model31 (white) 
including both the exon 9 loop and hydrophilic loop 1.    
 
Results and Discussion 
General dynamic structure of mature γ-secretase in a membrane 
As described above, despite major recent progress, the mechanistic understanding of γ-secretase seems 
to depend on the elusive, highly dynamic loop regions and disordered parts of the protein complex, 
including TM2 of PS1 very near the active site. Our multi-template “best of all worlds” model includes 
all complete transmembrane helices and the important loops from residues 71 to 467 for the first time, 
but also accounts for protonation states, realistic salt interactions, and the complex within the 
membrane. The model is shown in Figure 1A and 1B. The total RMSD measured between 5A63 and 
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5FN3 experimental structures is 0.3 Å, and the total RMSD between our new γ-secretase model and 
5A63 or 5FN3 is 0.6 and 0.5 Å, i.e. within the thermal fluctuation range (RMSD plots in Figure S1 and 
S2, units of nm) and thus in full agreement. The transmembrane topology is the most notable aspect of 
the general structure. The missing C-terminal residues added into Nicastrin (699−709) and APH-1 
(245−265) were well converged during the MD simulations (Supporting Information, Figure S3) and 
attained stable conformations as seen from RMSD plots (Figure S2). However, the most important 
major movements and associated new insight relates to PS1 as discussed further below. 
The three independent 500-ns ensembles provide a more complete estimate of the 
conformational variability in the general ensemble. The mature protein complex is a three-state system 
as seen from the principle component analysis, Figure S4. Though each simulation gave a distinct 
conformation from the last 200 ns (300−500 ns) used for clustering analysis, each also possesses other 
conformational states typical of the general ensemble that interconvert by crossing a relatively high-
energy barrier. The RMSD plots (Figure S1) of the three trajectories cross at several time points, also 
indicating recurrence, which supports the qualitative completeness of the sampling and the importance 
of the identified helix motions. 
Our model contains the large hydrophilic loop of PS1 (residues 273−374 from exons 8. 9, and 
10) positioned towards the cytosol between TM6 and TM7. The important auto-endoproteolysis that 
produces the mature complex occurs within exon 9 (residues 290−319)34 and is included in our model 
by cleavage at residue 298 (Figure S5). Sequential auto-cleavage begins at residue 292/293, followed 
by cleavage at 295/296, and ending with γ-like cleavage at 298/299 similar to that seen for other 
substrates34–36. The details of this cleavage process is beyond the scope of this work as the in vivo size 
distribution and specific role of this trimming remains unclear, and we were mainly interested in 
enabling free loop motions of the mature state. Although additional trimming of the remaining residues 
is unlikely to affect the dynamics of the system, the different isoforms could modulate C99 cleavage by 
e.g. competitive binding, but this needs to be explored in future work.  
Surprisingly, the large hydrophilic loop contains a loosely bound helix, a β-turn, and the 
remaining part as coil (the orange region in the bottom part of Figure 1B). These features are further 
enforced during simulation and are dynamically stable despite the sizable thermal fluctuations (Figure 
2) that explain why these structures have been elusive. The helical segment is repeatedly obtained and 
is dynamically stable in two of the three simulations. Whereas this structure is unknown from any 
direct experimental information, our findings agree well with NMR data being consistent with both the 
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presence of a β-turn and a loose α-helix segment within this loop37. While we find substantial helix in 
the loop, the cleavage region 292-298 was not helical in our simulations. Thus this particular segment 
is disordered but may undergo helix transitions as it approaches the membrane-embedded active site. 
Following the dynamic “plug” movement of this loop31, auto-proteolysis is presumably achieved after 
docking of the larger helical loop segment including the cleavage site of immature PS1. This provides a 
notable parallel to C99, whose Aβ fragment adopts helical structures in micelles38–40 – this would imply 
a common structure-based mechanism for the trimming during maturation and C99 processing22,41. 
PS1 cleaves APP-C99 and releases Aβ peptides of varying length ranging from 37 to 49 
residues7,8. Current drug development efforts focus on this cleavage, although the binding modes and 
explicit molecular features that cause the differential cleavage are not known. The prevailing current 
hypothesis is that imprecise positioning of C99 leads to changes in the step-wise trimming of the 
peptide along two major paths leading to Aβ40 and Aβ42 respectively14,18,22.  
It has been previously hypothesized that conformational flexibility within the catalytic subunit 
of PS1 affects cleavage24,29. Our previous PS1-alone simulations indicated that the membrane-packing 
of PS1 controls access to the active site31, consistent with more severe PSEN1 mutations in the 
membrane increasing the polarity of the protein and reducing its packing42. PCA on the last 200 ns of 
each trajectory produced the root-mean-square fluctuations (RMSF) for the first three eigenvectors 
(Figure 2). The most predominant motions reside in the large cytosolic hydrophilic loop region 
(273−374). Especially the residues 270−285, 317−328 and C-terminal of loop 360−373, where the 
structure is mostly coil, possess high RMSF values. These major motions resemble those seen for the 
isolated PS1 as described previously31; thus the major dynamics of free and complex-bound PS1 are 
qualitatively similar in this region. In addition, the loop (106−131) oriented towards the extracellular 
region and connecting TM1 and TM2 displays major motions, but the RMSF values are comparatively 
smaller than for free PS131, showing that the membrane-complex dampens these motions.  
Interestingly, high fluctuations are also observed in residues 141−165, corresponding to the C-
terminal end of TM2 (141−156), N-terminal end of TM3 (160−165) and a three-residue connecting 
loop. These residues lie directly opposite to the two catalytic aspartates D257 and D385 in TM6 and 
TM7, respectively, producing a cavity between them (Figure 3A). This cavity formed by TM2, TM3, 
TM5, TM6, and TM7 has been previously observed during sampling of PS1 conformational space 
through signal subtraction on cryo-EM image data and it was hypothesized to be the substrate binding 
region24. 
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Figure 2. Dynamics of PS1 ensembles. Root-mean-square fluctuations of the first three Eigen vectors 
of PS1 within γ-secretase extracted from the full trajectory in the membrane (colors red, green and blue 
refer to three independent simulations). Major movements correspond to loop and TM2 and TM3  
motions in PS1. 
 
Three distinct PS1 conformations of γ-secretase: Closed, semi-open, and open 
We examined the most representative structures obtained from clustering analysis of each γ-secretase 
simulation (Figure 3A) over the last 200 ns during which stable trajectories were observed (RMSD 
plots in Figure S1 and S2). Importantly, the three simulations visit three distinct conformation states, 
and these differences are almost exclusively occurring near the active site of PS1. State 1 represents a 
closed conformation of TM2 with most of TM2 (141−156) positioned close to D257 and D385. This 
“closed” state could plausibly exert steric control over any substrate binding, as explored further below. 
In state 2, TM2 obtains a distinctly more open conformation, whereas a small N-terminal part of TM3 
(160−165) has moved towards the two catalytic aspartates; thus this conformation is referred to as 
“semi-open”. The third state has both the C-terminal part of TM2 and the N-terminal part of TM3 in 
open conformations and is thus referred to as the (fully) “open” state. In Figure 3A, the closed, semi-
open and open states are shown in red, green and cyan color, respectively. The three conformational 
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basins are evident from free energy analysis of the principle components (Figure S4), which makes 
mature (but not immature) PS1 a remarkably multi-state protein compared with most other globular 
proteins. 
To quantify these conformational changes, we measured the average distance from the two 
catalytic aspartate residues (D257 and D385) to the C-terminal end of TM2 (141−156) (Figure 3B) and 
the N-terminal end of TM3 (160−165) (Figure 3C) during all three simulations. Initially, all three 
simulations started with an average distance of 18 Å between the C-terminal end of TM2 and the 
catalytic aspartates, representing the “static” picture known from electron microscopy structures (in the 
cryo-electron microscopy structure 5FN3, this distance is 17.2 Å). However, during the last 200 ns 
when the distinct conformational states had manifested, the closed state displayed a distance of only 
~14 Å, whereas the other two states displayed distances of ~19 Å. Interestingly, in the second 
simulation  (in which the semi-open conformation was observed), we observed open-close-open 
transitions that represent breathing modes of the γ-secretase dynamics. The complex started as an open 
conformation and attained a closed state after approximately 10 ns. Gradually after 300 ns, it again 
reached an open conformation (Figure 3B). Likewise, the initial average distance between the N-
terminal end of TM3 and the catalytic aspartates was 26 Å. While there is no significant difference in 
two of the simulations, the semi-open conformation has this distance contracted (21 Å, Figure 3C).  
As seen from the measured distances and from the general PS1 topology, TM3 is farther from 
the catalytic aspartates than TM2, and only six N-terminal residues showed substantial movements. 
Thus it seems implausible that TM3 alone can significantly affect substrate binding, but the interplay 
between its motion and the TM2 motion leads to a distinct semi-open state that not only reveals a 
general opening-closing process that is probably functionally important, but also directly affects 
substrate binding affinity, as investigated further below. The ensemble-averaged distances between the 
Cα atoms of the two catalytic aspartates are 10.7 Å in the semi-open conformation, similar to the 
experimental 5A63 structure (10.8 Å)25. The corresponding numbers for the open and closed states are 
13.4 and 11.6 Å (full ensemble fluctuations of this distance can be found in Figure S6). This distance 
is probably important for substrate cleavage precision and for the cleavage pathway initiation, and it is 
notable that the shortest distance coincides with a more compact, strong binding of peptides, as shown 
below. 
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Figure 3. Conformational changes in PS1. A) Representative structures of PS1, extracted from three 
individual γ-secretase simulations superimposed, zoom-in image of active site shown for better view. 
The three PS1 conformations closed, semi-open and fully-open are shown in red, green and cyan 
respectively. B. Average distance calculated from catalytic aspartates to B) C-terminal end of TM2 
(141-156) and C) N-terminal end of TM3 (160-165). The three time scale average distance plots in red, 
green and blue corresponds to closed, semi-open and fully open conformational states.   
 
Substrate binding to γ-secretase is controlled by conformation state 
As discussed above, the conformational dynamics affects the space within the substrate-binding region 
of γ-secretase. Once C99 is located within the protein complex, we hypothesized that the binding of 
different cleaved Aβ peptide products would depend on the space and the interactions within the 
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binding site. To understand this effect, we simulated the binding of both Aβ42 and Aβ40 to all three 
conformational states. Cleavage products of variable length differ in the C-terminal part that remains 
located within the substrate-binding site, whereas the similar N-terminal parts extend out to the 
extracellular side of the complex, and the two most prominent cleavage products were thus expected to 
probe differential binding well. To test sensitivity to protocol, we used both flexible (CABS-dock) and 
rigid (ZDOCK) docking programs. The CABS-dock program enables unbiased docking, which 
circumvents the problem of input bias, but requires smaller peptides for exhaustive searching, so we 
used Aβ11-40 and Aβ13-42 peptides for this method and compared it to the results obtained for the full 
peptides docked using ZDOCK.  
Figure 4 shows the conformations produced by CABS-dock of the most representative pose of 
Aβ11-40 (Figure 4A, B and C) and Aβ13-42 (Figure 4D, E and F) within the three representative 
structures of PS1. The structures with TM2 in a closed conformation (Figure 3A and 3B) are shown 
with docked peptides in Figure 4A and 4D; this conformation reduces the tendency of any substrate to 
bind near the active site, and thus we did not identify any conformation of Aβ11-40 and Aβ13-42 peptides 
near the catalytic aspartates. While the remaining two conformations display TM2 in an open 
conformation, the fully open conformation has the C- and N-terminal parts of TM2 and TM3 more 
open than the semi-open conformation. In the (fully) open state, excess space and lack of receptor 
contacts prevents binding of peptides near the catalytic aspartates (Figure 4C and 4F), implying that 
cleavage products of C99 are less strongly bound in this state. Interestingly, in the semi-open 
conformation the C- and N-terminal parts of TM2 and TM3 create optimal space for both Aβ11-40 and 
Aβ13-42 peptides to bind strongly near the catalytic aspartates (Figure 4B and 4E). Without prior 
knowledge of binding site, both Aβ peptides bind to the active site with the C-terminal end towards the 
catalytic aspartates; this implies that we may have located the dominant peptide-bound conformation 
state of γ-secretase. The main receptor-peptide interactions resulting from binding to this active semi-
open state are summarized in Table S1 (C-terminal part of Aβ40) and Table S2 (C-terminal part of 
Aβ42). 
To test this further, we used another program, ZDOCK, which uses a rigid docking protocol to 
dock substrates, but enabling the use of full peptides. Figure 5 shows the top conformations of Aβ40 
(1BA4) and Aβ42 (1IYT) NMR structures docked within the three top representative structures of PS1. 
Again, the closed TM2 conformation did not allow the Aβ peptides to bind inside the substrate-binding 
region; instead they bound on the verge of TM2 towards the extracellular region (Figure 5A and 5D). 
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This confirms the CABS results that we have identified the existence of a conformational state of γ-
secretase that is inaccessible to the peptide C-terminals. ZDOCK confirms that the open and semi-open 
conformations enable docking of Aβ peptides inside the substrate-binding region (Figure 5B, C, E and 
F). We also took the advantage of an available NMR structure for Aβ15-55 (PDB code: 2LLM) and 
docked this structure into the three PS1 representative structures by using ZDOCK program. While the 
semi-open and open conformations of PS1 successfully accommodate Aβ15-55 at the binding site, the 
closed conformation completely prevented the peptide from entering the active site (Figure S7).   
Accordingly, we conclude that the semi-open state is the most active and produce shorter 
isoforms, the closed state will be inactive, and the open conformation will be less active and have a 
shorter residence time of substrates, implying earlier release of cleavage product, and, in an ensemble 
average, increased long-short ratios but lower total turnover. This particular phenotype of lower 
activity combined with longer isoform formation is commonly seen in genetic PS1 variants30,42–44.  
 
Table 1. Top docking scores of Aβ40 and Aβ42 peptides docked into distinct protein conformations.  
PS1 conformation PDB code (length) ZDOCK score 
closed 1BA4 (1-40) 1617 
closed 1IYT (1-42) 1830 
closed 2LLM (15-55) 2246 
semi-open 1BA4 (1-40) 1974 
semi-open 1IYT (1-42) 2072 
Semi-open 2LLM (15-55) 2570 
fully open 1BA4 (1-40) 1750 
fully open 1IYT (1-42) 1642 
fully open 2LLM (15-55) 2486 
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Figure 4. Molecular binding of Aβ-type peptides to PS1. A−C) Aβ11-40 and D−F) Aβ13-42 peptides 
docked into the three representative structures of equilibrated PS1 within γ-secretase (red, green and 
cyan). Aβ peptides are colored in magenta with N- and C-terminals shown as blue and red spheres. The 
two catalytic aspartates are shown as orange spheres. 
 
The docking scores obtained from the ZDOCK program are collected in Table 1 and Table S3. 
The scores of the semi-open conformation are significantly higher (i.e. more favorable) than for the 
other two conformations, consistent with the finding from both complementary docking simulations 
that the semi-open conformation has optimal spatial constraints for receptor-peptide interactions. The 
results using both protocols thus support the same hypothesis that the semi-open conformation state 
provides the best fits of the Aβ peptides. This state will, according to a simple model where binding 
affinity scales with substrate residence time, produce the longest residence time of C99 cleavage 
products and therefore, the most complete trimming by the two aspartates. 
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Figure 5. Binding poses of NMR structures of Aβ to PS1. A−C) Aβ40 (PDB ID: 1BA4) and D−F) 
Aβ42 (PDB ID: 1IYT) docked into the three representative structures of equilibrated PS1 within γ-
secretase (red, green and cyan) using the ZDOCK program. Aβ peptides are colored in magenta with 
N- and C-terminals shown as blue and red spheres. Catalytic aspartates are shown as orange spheres.   
 
Dynamics of substrate binding and processing 
As described above, we explored the complete conformational dynamics of mature γ-secretase, 
including trajectories of all atoms, side chains, loops and helices, except the 70 first loop residues of 
PS1, in the membrane at physiological ion strength and pH using three seeded 500 ns simulations. 
Interestingly, the ensemble structures from clustering analysis reveal three distinct conformations of 
PS1 differing in the C-terminal part of TM2 and the N-terminal part of TM3 near the catalytic 
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aspartates. The open-close-open breathing dynamics of TM2 changes the space available in the active 
site (Figure 3A and Figure S8). While the C-terminal end of TM2 (141−156) and N-terminal end of 
TM3 (160−165) are directly connected by a short loop, movement of one region is hindered by the 
other and by nearby TM5, TM6 and TM7 helices. These motions are the major ones beyond loop 
motions, they recur repeatedly and interconvert, suggesting their primary relevance to the overall 
ensemble. 
These conformational changes may have a direct effect on substrate processing. To support this 
hypothesis, two complementary types of docking simulations revealed that Aβ peptides bind 
substantially stronger in one conformation, the “semi-open” state (Figure 4B and 4E). Of the two 
conformations where Aβ peptides could not fit the PS1 active site, one has TM2 in a closed 
conformation (Figure 4A and 4D) and the other has a too open conformation (Figure 4C and 4F).  
The main explanations for altered γ-secretase processing relate to the impact of the active site 
topology, the orientation of the substrate within the cavity in several binding cavities, and the precision 
of cleavage18,19. Bolduc et al.18 found three binding pockets in PS1 that can accommodate three residues 
from substrates for successive tri-peptide cleavage; long-range motions specific to PS1 may explain 
why some mutations far from these pockets increase Aβ42/Aβ40 ratios31. From both studies, it emerges 
that tight substrate-enzyme interaction is needed for a precise cleavage. Since our identified semi-open 
conformation produces optimal spatial constraints for binding, we mapped the residues around our 
docked Aβ15-55 peptide within 4 Å. Several aromatic residues (F, Y and W) are arranged as a ladder, 
pointing their side chains towards the peptide. Y256 and F388 are close to the catalytic aspartates 
(Figure S9) and are likely constituents of the pocket observed by Bolduc et al.18 
Although these features will affect the two general pathways leading to Aβ40 and Aβ42, our 
detailed all-atom dynamics and docking simulations point towards a previously overlooked mechanism 
that may critically determine trimming extent, namely residence time of the C99-derived peptide 
substrates during step-wise cleavage. This model is explained below: 
Kinetic studies on enzymes and their transition states generally suggest that the active sites of 
enzymes are flexible and tend to close around substrates to maximize binding contacts45,46. Kinetic 
studies of wild type and FAD-related mutations of PS1 have revealed diverse effects on kinetic 
parameters Vmax and kcat. These experiments demonstrate that FAD mutants affect Aβ cleavage in three 
different ways that include both loss of general catalytic activity and gain of toxic function47, most 
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commonly in the form of increased Aβ42/Aβ40 ratios42,48–50. Importantly, hypomorphic mutations with 
lower overall activities tend to increase the relative amount of longer isoforms42. In addition, 
intramembrane proteolysis by γ-secretase features kcat =  0.0012 s−1, which is very low compared to 
soluble proteases (> 1s−1)51. A similarly low kcat of 0.0063 ± 0.00021 s−1 was observed for rhomboid 
protease, another intramembrane protease involved in Parkinson’s disease52. Accordingly, 
intramembrane proteolysis occurs on a time scale of minutes, and therefore a substrate must remain in 
the active site long enough to be cleaved41. γ-secretase cleaves C99 at multiple sequential sites7,8, and 
thus stronger and longer substrate binding becomes a critical, overlooked feature of substrate trimming.  
Our dynamic simulations and docking results show consistently that the conformations of the 
complex affect the substrate affinity differently: TM2 moves closer to the catalytic residues in the 
closed state to substantially reduce the substrate binding cavity formed by TM2, TM3, TM5, TM6 and 
TM7 (Figure 3A). As seen from the docking scores, this closed conformation cannot bind peptide 
products of the types docked, and the C99 peptide will be even less able to enter the substrate-binding 
region, causing reduced activity, i.e. the closed conformation represents a loss-of-function tendency of 
the ensemble (Figure 6A and 6D). The overall kinetic scheme representing these findings is shown in 
Figure S10. 
In contrast, the other two states have TM2 in an open conformation. In the semi-open 
conformation, the N-terminal region of TM3 moved towards catalytic aspartates (D257 and D385) to 
provide optimal fits for continued processing of the substrates, and the affinity is consistently larger in 
this optimal-bind state (Table 1) and by inference, increases the rate of catalytic reaction (Figure 6B 
and 6E). This state thus represents the functional, optimal trimming state that we conclude should be 
preserved or enforced by molecular intervention strategies. In contrast, the (fully) open conformation 
has less optimal packing interactions and will thus keep peptides for shorter time and cause less 
trimming but also represents lower overall catalytic activity because of the generally reduced substrate 
affinity: This leads to premature dissociation of substrates which explains the generation of longer form 
of Aβ (Figure 6C and 6F). We thus identify this open conformation with the common “hypomorphic” 
PS1 mutant phenotype that increases long-short ratios. Out of two conformations where Aβ peptides 
failed to dock in PS1 active site, one has TM2 in closed conformation (Figure 4A and 4D) and the 
other has it open (Figure 4C and 4F).  
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Figure 6. Model of C99 binding to conformations of PS1. Two perpendicular views of A, D) closed, 
B, E) semi-open and C, F) fully-open states of PS1 with N- and C-terminal fragments colored cyan and 
pink, respectively. The transmembrane region of C99 is shown as red cylinders, and the two catalytic 
aspartates as orange spheres. A, D) The closed conformation prevents substrate binding. B, E) The 
semi-open conformation maximizes substrate receptor contacts, residence time, and trimming. 
Stepwise translocation of C99 from PEN-222 implies a plausible C99 route into the semi-open 
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conformation. The red arrow shows the entry route of C99 between TM2 and TM6 helices. The blue 
arrow depicts the outward movement of TM2. C, F) The open conformation displays excess space and 
insufficient substrate contacts, weaker binding, and earlier dissociation of presumably longer peptides 
(a phenotype commonly seen in FAD mutants). G-I) show the models in perspective with extracellular 
side upwards.  
 
Although quantitative details will depend on the choice of force field, the sampling protocol, 
and the exact membrane system used, the observation of recurrence of the main states and the close 
contacts preventing broader motions of TM2 and TM3 support the completeness and relevance of these 
particular helix motions, and on this basis the proposed dynamic model of substrate processing seems 
qualitatively correct. It is notable that the “open” and “closed” conformations that we identify, which 
relate to TM2 and TM3 movement, active site space and substrate recruitment, are distinct from the 
previously proposed “open” and closed” states by Berezovska et al.53 which relate to the distance 
between N-terminal and C-terminal parts of the protein on the opposite side of the protein (Figure 
S11). 
Recent photo-crosslinking studies by Fukumori et al.22 determined the N-terminal fragment of 
PS1 as the principal substrate-binding site. They also identified residues V44, L49, M51 and L52 from 
C99 as major γ-secretase interaction sites. In addition, they identified secondary substrate binding sites 
in PS1 NTF, Nicastrin and PEN-2 that aid substrate translocation towards the active site. Combining 
these findings of stepwise substrate recruitment with our dynamic structural model, Figure 6E shows 
the most plausible substrate recruitment route to reach the active site. During stepwise binding from 
PEN-2 to the active site, the loop regions between TM 2/3, 3/4 and 4/5 of PS1 NTF act as main 
barriers. A possible route where the connecting loop is absent is through TM2 and TM6. We showed in 
our previous PS1-alone study31 that TM2 moves outwards and thus potentially allows substrates to 
reach the active site through the TM2 and TM6 “doors”. Interestingly, in GlpG, a Rhomboid-family 
intramembrane serine protease, TM5 bends outwards to provide access to substrates in a similar way54, 
and Chang et al.55 showed reversible pH-dependent open-close conformations in TM2 of 
transmembrane Bax inhibitor-1 protein, a calcium transporter with two aspartates located in a way 
similar to PS1, which has also been implied in calcium transport; we previously argued that calcium 
channel function and these motions seem coupled31. Also, the observed tendency that γ-secretase in 
thicker membranes produces less of the long Aβ isoforms56 can be reconciled with our residence time 
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model because thicker membranes favor the membrane-protein packing, tight C99 association and 
longer residence time, as described in our model. 
Our model (Figure 6A-F) also provides a molecular structural basis for the processing 
phenotypes of PS1 mutations as discussed previously20. Different mutations are likely to affect one or 
more of these conformational states in specific ways, but the most common PS1 phenotype, which 
features loss of general function combined with increased long-short ratios, is characteristically 
obtained by favoring the open conformation of γ-secretase, whereas the semi-open “innocent” 
conformation is reduced in PS1 phenotypes. Our model is supported by the reduced dissociation rates 
of Aβ42 from γ-secretase treated with γ-secretase modulators, and the increased dissociation rates of 
PS1 FAD mutants vs. wild type57, and agrees with chemoinformatics showing that severe PS1 
mutations tend to reduce hydrophobicity more, and this correlates directly with higher Aβ42/Aβ40 
ratios42, and explains why less proficient forms of the protein complex commonly produce relatively 
longer isoforms, because binding and effective trimming requires optimal hydrophobic and hydrophilic 
receptor-substrate contacts. Utilizing these conformations as targets for specific interventions can, we 
think, provide a molecular recipe of conformation-selective γ-secretase modulators as AD 
medicine41,58.                 
 
Methods 
Construction of atomic models  
Recently, multiple γ-secretase structures have been determined by cryo-electron microscopy (PDB 
codes: 4UIS, 5A63, 5FN2, 5FN3, 5FN4 and 5FN5)23–25. In order to utilize the maximum template 
coverage, we compared each γ-secretase subunit in all available experimental PDB structures. While a 
complete structure of PEN2 is available, C-terminal residue segments of length 11 and 21 were missing 
in Nicastrin and APH1, respectively (PDB codes: 5A63, 5FN2, 5FN3 and 5FN4). The catalytic sub-
unit PS1 lacks several features: All available PS1 structures lack the large cytosolic hydrophilic loop 
region (residues 273−374 of exons 8, 9 and 10) where auto-proteolytic maturation occurs34. Also, TM2, 
which is situated close to the catalytic site and the extracellular hydrophilic loop 1 and has been 
implied as having a dynamic role in the protein25,31, is absent in the highest-resolution structure (5A63) 
at 3.4 Å25. However these regions become well-ordered due to the binding of a kinked α-helix from a 
co-purified protein in PDB structure 5FN3 at 4.1 Å resolution24.   
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To produce the most complete model possible, we used PS1 from PDBID 5FN324 and the PS1 
model that we developed previously31, which is very similar in overall topology to the best-resolution 
structure of PS1 (5A63 at 3.4 Å) but importantly includes the large hydrophilic loop region and 
accounts for the high-resolution features of TM1−TM9. By using the two structures as templates, we 
generated a multi-template model using the MODELLER 9.14 software59. Our new multi-template PS1 
model uniquely covers all atoms from residues 71−467, and misses only the N-terminal 1−70 segment 
that is elusive in all experiments so far due to high disorder25.  
After aligning the coordinates of our PS1 model onto the PS1 coordinates of 5FN3, we 
extracted the coordinates of all four subunits (including newly modeled PS1) into a single coordinate 
file; this produced a best-of-all-worlds model of the topology and helices while including our 
previously modeled and fully sampled loop regions that are experimentally undetermined. Structural 
constraints and bad contacts in the new integrated structure were reviewed and refined using the 
Protein Preparation Wizard tool of the Schrodinger suite60. Using the multi-chain model scripts 
available in MODELLER 9.1459, we added the missing C-terminal residues into Nicastrin (699−709) 
and APH1 (245−265) to generate a complete γ-secretase structural model, the most complete so far 
(Figure 1A). This model was then subject to MD simulations in an extensive membrane-solvent 
system to provide a realistic, physiologically relevant membrane environment for the protein, as 
described below. 
We produced the mature model from the structurally optimized non-mature PS1 structure by 
separating the oxygen and nitrogen atoms of M298 and A299 at 6 Å. Subsequently one oxygen atom 
and two hydrogen atoms were added to CO and NH groups of M298 and A299 respectively using 
Pymol to produce N-terminal (71−298) and C-terminal (299−467) fragments of mature PS1 (Figure 
1B). 
 
Membrane simulation setup 
Although γ-secretase is a membrane protein complex, the available experimental structures do not 
feature the protein in the context of a membrane; the membrane is expected to affect substantially the 
protein dynamics as indicated by a previous membrane dynamics study of PS131. We therefore aimed 
to produce a realistic membrane model of the protein complex by embedding the new γ-secretase 
model into a membrane-solvent bilayer system (Figure 1A) using the membrane builder tool of the 
Page 19 of 37
ACS Paragon Plus Environment
ACS Chemical Neuroscience
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
20 
 
CHARMM-GUI web server61,62. We oriented the protein in membrane using the PPM (Position Protein 
in Membrane) server63. The output from the PPM server was used as input to the membrane builder 
tool. A homogeneous POPC lipid bilayer was generated around the protein by maintaining a water 
thickness of 12 Å above and below the protein complex. Ion strength and salt impacts the 
conformations of proteins64,65, and studying γ-secretase conformational changes with realistic salt 
conditions is thus necessary. To simulate a physiological ion concentration and to neutralize the −18 
total charge of the complex, 0.15 M NaCl (165 Na+ and 147 Cl− ions) was placed using Monte-Carlo 
randomization.  
MD simulations were performed using the GROMACS 5.0.4 package66,67 and the Charmm36 
force field68, which is compatible with the membrane lipid parameters, and TIP3P69 as explicit water 
model. The Verlet70 cut-off scheme was used to treat non-bonded interactions with a cut-off for short-
range Coulomb and Lennard-Jones interactions of 12 Å. Long-range electrostatic interactions were 
calculated using the Particle Mesh Ewald71 algorithm. The Linear Constraint Solver (LINCS) 
algorithm72 was used to constrain all covalent bond lengths. A steepest descent algorithm73 was applied 
to minimize the complete protein-lipid-solvent system, followed by six-step position-restrained 
equilibration for 375 ps to relax the atomic positions. During the first two steps, the system was 
equilibrated in a canonical (NVT) ensemble using Berendsen74 temperature coupling, and in the next 
four steps equilibration was achieved within the isothermal-isobaric (NPT) ensemble using the 
Berendsen74 temperature and pressure couplings62. Finally, three independent 500-ns production 
simulations were carried out for the membrane-bound γ-secretase within an NPT ensemble using the 
Nose-Hoover thermostat75 and Parrinello–Rahman barostat76 at 303.15 K and 1 atm, respectively. 
 
Principal component analysis (PCA) 
We used PCA to systematically reduce the dimensionality of our simulated data and extract underlying 
essential dynamics77. The correlations between the motions of particles produce the structure of total 
fluctuations. In a system of N atoms, 3N-6 modes of internal fluctuations are possible. The covariance 
between each pair of atoms is described by a matrix: 
( )( )Xjjiiij xxxC −−=     (1) 
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Equation 1 represents the covariance matrix in which xi and xj are Cartesian coordinates of particles i 
and j, respectively, and 〈 〉 is the ensemble average of all structures across the equilibrated (last 200 ns) 
simulation time scale. Diagonalization of the symmetric covariance matrix C solves the eigenvalue 
problem, 
 =       (2) 
 
where A represents the eigenvector and λ is the associated eigenvalue. To focus on the catalytically 
relevant part of the protein complex, Cα atoms of the PS1 subunit were used in the covariance analysis. 
We applied the g_covar tool of the GROMACS package66,67 to calculate and diagonalize the covariance 
matrix. The Eigenvectors define the direction of collective motion of the atoms and the eigenvalues 
define how much total variance or motility is associated with each eigenvector; typically >90% of the 
variance is described by <10 eigenvectors or principal components78. We used the g_anaeig tool of the 
GROMACS package66,67 to extract the most dominant fluctuations for further analysis. 
 
Clustering analysis 
To analyze the most frequently visited conformations of γ-secretase we performed ensemble-average 
clustering analysis by using the g_cluster tool of the GROMACS package66,67. The clustering algorithm 
is described by Daura et al79; we used a backbone root-mean-square deviation threshold of 2 Å. The 
last 200 ns of each simulation, which represent stable conformational ensembles as seen from RMSD 
plots (Supporting Information, Figure S1), were used in the clustering analysis. Based on the RMSD 
cut-off the algorithm groups all the structures into representative clusters of the ensemble and defines 
the structure with highest number of neighbor conformations as representative structure in each 
cluster79. 
 
Peptide docking simulations 
Models of relevant parts of C99 and Aβ peptides were docked into the representative cluster structures 
of all three seeded simulations using the molecular docking simulation programs CABS-dock80,81 and 
ZDOCK 3.0.282,83, which complement each other well: Without prior knowledge of the binding site, 
CABS-dock uses flexible docking of the peptides into the protein. The program performs a binding site 
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search by allowing full flexibility of the peptide and small fluctuations of the protein backbone, while 
keeping the protein structure near to the equilibrated conformation by a set of distance restraints. The 
docking protocol has been tested on a benchmark set of 103 bound and 68 unbound protein receptors81. 
The program selects the realistic conformations (poses) based on the K-medoids clustering method81. 
Due to the limitation in allowed peptide length of CABS-dock, the relevant C-terminal parts 
corresponding to peptides Aβ11-40 and Aβ13-42 were docked; the C-terminal is residing within the 
binding pocket whereas the N-terminal parts are outside in solution, so this is not likely to affect the 
substrate binding dynamics substantially. Considering the limitation in docking programs and the lack 
of knowledge regarding the Aβ binding mode, we excluded the clusters where Aβ peptides docked 
with the hydrophilic N-terminal inside the hydrophobic active site due to the high energy of such poses. 
To validate this protocol, we also used another program, ZDOCK, which is a rigid docking program 
which searches all possible binding modes between receptor protein and peptide in the translational and 
rotational space, and which can handle the full Aβ peptides. Finally each pose is evaluated by an 
energy scoring function84. We provided the two catalytic aspartates D257 and D385 from PS1 and 
V36−A42 from Aβ40-42 as binding site residues. Residues G37−A42 belong to the sequential tripeptide 
proteolytic cleavage region G37−T48/L49 of longer Aβ forms (Aβ48 and Aβ49 derived from ε-
cleavage), which serve as suitable peptide binding residues near the catalytic aspartates7,8.  
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